In other cries of the week: Dr. Dre issues a cease and desist letter to Marjorie Taylor Greene claiming copyright infringement. Apple lost a patent lawsuit threatening importation of certain of her Apple Watches. And a jury ruled in favor of fashion designer Thom Browne over Adidas in a trademark case.
Part-Time Job
USPTO Extends Deadline for Comments on Initiative to Expand Opportunities for Pre-Office Practice – On Friday, January 13, the United States Patent and Trademark Office (USPTO) announced an extension to the comment period related to two October 2022 Federal Register notices. Registered to practice patent litigation in the US Patent and Trademark Office. The comment period was originally scheduled to end on January 17, 2023, but has now been extended to January 31, 2023. Comments can be submitted here, and comments already submitted can be found here and here.
Adidas loses ‘three stripes’ trademark lawsuit against fashion designer
On Thursday, January 12, a jury in New York ruled against Adidas in a $7.8 million lawsuit against fashion designer Thom Browne for allegedly infringing on Adidas’ “Three Stripes” trademark. Bloomberg methodThe controversy has dragged on for more than 15 years, with Adidas initially accusing Braun of copying its own designs. Braun then changed the design to a “four-bar” design. Braun’s attorney said Adidas “does not own Stripe.”
The ITC rules that Apple infringes its pulse oximeter patent.
On Tuesday, January 10, a US International Trade Commission (ITC) judge ruled that Apple had infringed Masimo’s pulse oximeter patent. The technology in question is used in the Apple Watch.”Today’s decision should help restore fairness in the market,” Masimo CEO Joe Kiani said in a statement. And we believe today’s ruling will make it clear that Apple is a company that takes innovations from other companies and repackages them.” I plan to consider
Dr. Dre issues cease and desist letter to Marjorie Taylor Green
On Monday, January 9, Dr. Dre’s legal representative confirmed that Rep. Marjorie Taylor-Greene (R-GA), a Republican of Georgia, performed his song “Still DRE” in a video posted on her Twitter account. I have sent a cease and desist letter. In the letter, the musician’s attorney accuses the controversial congressman of violating Dr. Dre’s copyright. Lawyers write: But the laws governing intellectual property can be too arcane and unpopulist for you to actually spend much time on. The video has since been removed from Green’s Twitter account.
Supreme Court Denies Juno’s Request for Retrial in Patent Dispute with Kite Pharma
On Monday, January 9, the U.S. Supreme Court denied Juno Therapeutics, a subsidiary of Bristol-Myers Squibb, in its patent infringement lawsuit against Gilead Sciences, Inc. against Kite Pharma. In 2021, the court initially ruled in favor of Juno Therapeutics in a lawsuit against Kite Pharma over alleged patent infringement of an immuno-oncology drug. However, the patent infringement and her subsequent $1.2 billion settlement were vacated by the Court of Appeals for the Federal Circuit (CAFC). The High Court dismissed Juno Therapeutics’ petition filed in November 2022, but subsequently petitioned for a rehearing, amgen vs sanofi Need to reconsider. Both cases deal with the meaning and scope of the validation requirements of 35 USC § 112.
Burks
CAFC remands portion of probationary deed patent infringement litigation
On Thursday, January 12, the CAFC issued a precedent decision reinstating Grace Instrument’s portion of its patent infringement lawsuit against Chandler Instruments related to oil drilling technology. The CAFC ruled that the district court erred by considering the dictionary definition of “enlarged room,” instead of considering how craftsmen would interpret the meaning. The CAFC wrote, “We have considered Grace’s remaining arguments and do not find them persuasive,” but the court reversed some of the district court’s decisions and remanded these issues to the lower courts. rice field. Read more about the case here.
PTAB rules against Google in smartphone patent litigation
On Wednesday, January 11, the Patent Trial and Appeal Board (PTAB) ruled against Google in a patent dispute against smartphone company Neonode. The PTAB found that Google has not provided sufficient evidence for 13 claims that the Neonode patent is unpatentable. Last month, Neonode also lost a similar lawsuit from Samsung.
USPTO issues gun detection patent
On Wednesday, January 11, the United States Patent and Trademark Office (USPTO) issued a patent to ZeroEyes for an AI-based gun detection video analysis platform. The platform identifies guns and quickly sends information to first responders.
AI creators demand copyright from court
On Tuesday, January 10, computer scientist Stephen Thaler filed a lawsuit in federal court asking for copyright law to apply to AI-generated art. The U.S. Copyright Office refused to register Thaler’s copyright, citing its “human authorship requirement” policy, which requires artwork to be created by a human. However, Thaler’s lawyer argued that since he created the AI, he should be able to obtain the copyright for the artwork he commissioned his AI to create.
PTAB Finds Pilot’s Claims in Car Charger Patent Unpatentable
On Monday, January 9, the PTAB ruled in two separate decisions that substantially all of the claims in Pilot Inc.’s car charger patent pair are unpatentable. two petitions between the parties The review was submitted by Shenzhen Chic Electrics Co and Noco Company.
wall street this week
Bankman-Fried defends action in Substack Post
On Thursday, January 12, FTX founder Sam Bankman-Fried, who is currently under house arrest on federal fraud charges, announced his defense of his former company’s actions against Substack. Bankman-Fried released his balance sheet in the post, claiming his innocence, saying, “I didn’t steal the funds and I didn’t hide billions of dollars.” His new FTX CEO, John Ray III, who previously oversaw the liquidation of Enron, said of FTX:
Moderna considering quadrupling the price of its COVID vaccine
Monday 9th January, wall street journal Moderna reported that it is considering raising the price of a single dose of its COVID-19 vaccine from $26 per dose to $110 to $130 per dose. “We think this type of pricing aligns with value,” said Stephan Bancel, CEO of Moderna. I’m facing
Quarterly results – The following companies, identified among the IPO’s top 300 patentees for 2021, will report quarterly results next week (2021 rankings in parentheses):
- Monday: United Microelectronics Corporation (190th)
- Tuesday: none
- Wednesday: none
- Thursday: Procter & Gamble Company (78th)
- Friday: Schlumberger (100th)
Image Source: Deposit Photo
Image ID: 8650807
Author: branch
